You are looking for a tip – “Get Ready to Overcome Malaria” … a slogan that is now being raised at this global hour of malaria control Paris News Date: Tuesday, 17 April 2018 08:39 AM Paris News – Cairo – (ASA): The World Health Organization (WHO) and its partners will kick off on April 25 at this global hour of malaria control 2018 under the theme “Get Ready to Beat Malaria”, which emphasizes collective energy and the global malaria community’s commitment to the common goal of a malaria-free world. It also highlights the remarkable progress made in tackling one of the oldest human diseases, while calling for worrying trends as outlined in the Global Malaria Table 2017. The global response to malaria is at a crossroads, following an unprecedented period of success in combating malaria , Where this progress has been halted. The current pace is insufficient to meet the 2020 targets of WHO’s Global Malaria Control Strategy for the period 2016-2030, specifically the goals of a 40% reduction in malaria and mortality rates. Countries with continuing transition are increasingly deteriorating into one of two categories: those moving towards elimination; and those with a high burden of disease, which have reported significant increases in malaria cases. Without urgent action, major gains in malaria control are under threat. At this time of the World Malaria Day, WHO continues to advocate increased investment and expanded coverage of proven tools that prevent, diagnose and treat malaria. The World Health Organization (WHO), at its 60th session in May 2007, identified 25 April as the International Day for the Eradication of Malaria, an opportunity to recognize global efforts to combat malaria effectively. It has now been established at this time of the World Malaria Day because of the efforts being made throughout Africa to commemorate the African Malaria Day. Malaria is a parasitic disease caused by a parasitic organism called Plasmodium. It is transmitted by mosquitoes. This parasite infiltrates the red blood cells of the human body and destroys them. This is accompanied by a variety of symptoms, including fever, anemia and swollen spleen. The malaria parasite was discovered on 6 November 1880 at the military hospital in Constantine, Algeria, by a French army doctor named Alphonse Lafairn, who won the Nobel Prize in Medicine and Physiology in 1907 for his discovery. The disease spreads in third world countries and is transmitted to children in many ways, most notably mosquitoes, which are frequent after rainfall, especially in areas where there is no sanitary drainage of rainwater and sewage. Anopheles mosquitoes are the most capable of transmitting the malaria parasite while absorbing the human blood they need to be able to lay eggs, noting that mosquitoes do not feed on the blood but on the nectar of flowers and the juice of plants. Malaria is a severe febrile disease and symptoms in people who have no immunity against it after seven days or more (10 to 15 days often) are exposed to mosquito bite. The first symptoms may be fever, headache, tremor and vomiting, Symptoms are mild and may be difficult to return to malaria. Research has confirmed that pregnant women are more likely to become infected with malaria than non-pregnant women because the immune system may weaken during pregnancy, which means that the body is less resistant to bacteria and infections. If the pregnant woman has malaria, her child may also become ill. According to the latest World Health Organization (WHO) estimates released in December 2017, the global response to malaria is at a crossroads, and gains are declining after unprecedented global success in malaria control, progress has slowed down, according to the report on malaria In the world in 2017. “In recent years, we have made major gains in the fight against malaria, but we are now facing a turning point,” said Dr Tidros Adhanum Ghebriissos, Director-General of the World Health Organization. Without urgent action, we are at risk of falling back and failing to meet the global targets related to malaria for 2020 and beyond. The WHO Global Technical Strategy on Malaria 2 calls for a reduction in the incidence and mortality of malaria by at least 40% by 2020. According to FAO’s latest malaria agenda, the world is not on track to reach these critical milestones. Lack of funding both domestically and internationally is a major problem, with significant gaps in the coverage of insecticide-treated bed nets, medicines and other life-saving tools. The global malaria calendar for 2017 is based on data from 91 countries and regions with persistent malaria transmission. Information is supplemented by data from national household surveys and databases maintained by other organizations. It also outlines the current status of the world’s progress in malaria control through the end of 2016. The report tracks the progress made in the areas of investment in malaria research and prevention programs, malaria prevention, diagnosis and treatment, and monitoring of trends related to the burden of the disease, Progress made in eradicating malaria, addressing threats associated with addressing them and maintaining the investments made in this regard. The number of malaria cases in 2016 worldwide is estimated at 216 million, 237 million in 2010 and 211 million in 2015, the report said. Most cases of malaria in 2016 occurred in FAO’s African Region (90%), followed by Southeast Asia (7%) and Eastern Mediterranean Region (2%). Out of a total of 91 countries that reported original cases of malaria in 2016, 15 are all in sub-Saharan Africa. The global malaria incidence rate between 2010 and 2016 is estimated to be 18%, from 76 to 63 cases per 1000 population at risk. FAO’s South-East Asia Region recorded the highest rate of infection with 48%, followed by the Americas (22%) and the African Region (20%). Despite these declines, the incidence of malaria between 2014 and 2016 has seen significant increases in the WHO Region of the Americas and slightly in FAO’s South-East Asia, Western Pacific and Africa regions. Parasitic parasites are the most common malaria parasites in sub-Saharan Africa, accounting for 99% of estimated malaria cases in 2016 in the African Region. Outside of Africa, P. vivax parasites are the dominant malaria parasites in the WHO Region of the Americas, accounting for 64% of malaria cases in this region, more than 30% of malaria cases in South East Asia and 40% In the WHO Eastern Mediterranean Region. New data from improved surveillance systems in several countries in the WHO African Region indicate that the number of malaria cases shown in this year’s calendar is conservative. In 2018, WHO will review its methods of assessing malaria burden in sub-Saharan Africa. The number of global malaria deaths in 2016 is estimated at 445,000, while in 2015 it was estimated at 446,000. The WHO African Region recorded 91% of the world’s total malaria deaths in 2016, followed by 6% in Southeast Asia. Fifteen countries recorded 80% of the world’s malaria deaths in 2016, all in sub-Saharan Africa, with the exception of India. All regions recorded a reduction in malaria mortality rates in 2016 relative to their rates in 2010, with the exception of the Eastern Mediterranean Region, where malaria mortality rates had not actually changed in that period. The largest declines were recorded in South-East Asia regions: 44%; Africa 37%; and the Americas 27%. Between 2015 and 2016, however, mortality rates were found in FAO’s South-East Asia and Western Pacific regions, while in the regions of Africa, the Eastern Mediterranean and the Americas of WHO. More countries are on the verge of eradicating malaria. In 2016, 44 countries reported fewer than 10,000 cases of malaria, up from 37 in 2010. In 2016, the World Health Organization (WHO) of Kyrgyzstan and Sri Lanka saw malaria disappear. In 2016, FAO identified 21 countries with potential malaria elimination by 2020. FAO works with these countries, known as the “Potential malaria elimination by 2020” group, to support their respective goal of accelerating malaria eradication. Although some countries where malaria is likely to be eradicated by 2020 are still on track to achieve malaria elimination, 11 have reported an increase in the number of original malaria cases since 2015, while five have reported an increase The number of cases in 2016 of their number in 2015 by more than 100 cases. Some of the challenges hampering countries’ ability to stay on track and progress towards malaria eradication are the lack of predictable sustainable international and domestic funding, the risks of conflict in some malaria-endemic areas, abnormal climatic patterns, and the emergence of malaria-resistant antimalarial drugs , Mosquito resistance to insecticides. WHO is currently supporting malaria emergency response operations in Southern Sudan, the Bolivarian Republic of Venezuela, Nigeria and Yemen, where humanitarian crises in these countries pose serious health risks. In the state of Borno, Nigeria, the organization supported the launch of a campaign to provide antimalarial drugs on a large scale, reaching 1.2 million children under the age of five in targeted areas, according to estimates. Initial findings indicate a reduction in the number of malaria cases and deaths in the state.
In the past three years (2014-2016), the average per capita share of malaria risk has fallen from the funding available in 34 of the 41 malaria-burdened countries that rely mainly on external funding for malaria programs over the 2011/13 average. Pakistan, the Democratic Republic of the Congo, Senegal, Guinea, Mauritania, Mozambique and Niger, which recorded an increase in this average. The per capita malaria risk of funding in the 41 malaria-burdened countries remains below US $ 2 total. High levels of cheating of the heptide-2 protein gene in some places threaten the ability to diagnose and treat patients with sickle cell disease. The absence of this gene enables parasites to hide when detected by the rapid diagnostic test of the histidine-rich protein (HRP2), resulting in a false negative result. Although the prevalence of cases of hepatic gene production of hestidine-rich protein is still low in most countries with high malaria incidence, monitoring needs to be increased. In drug resistance to malaria, artemisinin-based combination therapy has been an integral part of the success of global malaria control efforts recently and its effectiveness in the treatment of malaria is a global health priority. Although multidrug-resistant cases, including artemisinin (partial) resistance and other combination drugs, have been reported in 5 countries of the Greater Mekong Subregion, the subregion has seen a dramatic reduction in malaria cases and deaths. The monitoring of the effectiveness of antimalarial drugs in that region has resulted in timely updates of the all-encompassing therapeutic policies. To date, there have been no cases of partial resistance to artemisinin in Africa, and the first line of artemisinin-based combination therapies is still effective in all malaria-endemic areas. Regarding insecticide resistance, of the 76 malaria-endemic countries, data were provided for the period from 2010 to 2016. In 61 countries, resistance to at least one vector of malaria was detected from one site collected for one Pesticide. In 50 countries, resistance to two or more insecticides has been reported. In 2016, there was a resistance to one or more insecticides in all WHO regions, although their monitoring ranges varied. The resistance of malaria carriers to pyrethroids is widespread, and is the only type of insecticide currently used in the manufacture of insecticide-treated bednets. The percentage of malaria-endemic countries increased and their vector resistance to pyrethroids was reported and reported from 71% in 2010 to 81% in 2016. The level of prevalence of confirmed pyrethroid resistance varied across regions and was highest in the WHO African and Eastern Mediterranean regions, For the resistance of malaria carriers to these compounds in more than two thirds of the total sites observed. Insecticide-treated bednets remain an effective tool in preventing malaria, even in areas where mosquitoes are resistant to pyrethroids. This has been demonstrated by a large multi-country evaluation exercise coordinated by FAO between 2011 and 2016, as there is no link between malaria burden and pyrethroid resistance at various sites studied in five countries. On investments targeted at malaria control and elimination, the report states that in 2016, the investments of governments of malaria-endemic countries and international partners in malaria control and elimination efforts in the world were estimated at about US $ 7 billion. Most of the investments implemented in 2016 in the African Region of the World Health Organization (WHO) were spent 74%, followed by South East Asia (7%), the Eastern Mediterranean, the Americas (6%) and the WHO Pacific (4%). Governments of malaria-endemic countries contributed 31% of total funding in 2016 (US $ 800 million). In 2016, the United States was the world’s largest source of funding for malaria control and eradication efforts, giving one billion US dollars, accounting for 38 percent of the total funding, followed by the United Kingdom of Great Britain and Northern Ireland and other donor countries, And Japan. More than half of the resources (57%) are monitored in 2016 through the Global Fund to Fight AIDS, Tuberculosis and Malaria. Although funding for malaria control and eradication efforts has remained relatively stable since 2010, the level of investment in 2016 was well below the level required for achieving the first milestone of the Global Technical Strategy on Malaria, namely the reduction in the incidence of malaria and the malaria mortality rate The world will be at least 40% for their rates in 2015. To achieve this milestone, the global technical strategy on malaria estimates that global funding will need to increase to US $ 6.5 billion annually by 2020. However, Mel Arya and eliminate it in 2016, a seven-billion-dollar “US dollar”, representing less than half of the estimated amount in the strategy (41%). Increased investment in research and development related to malaria control and elimination is a key factor in achieving the goals of the Global Technical Strategy on Malaria. US $ 572 million was spent in this area in 2015, representing 83% of the estimated annual amount of R & D. The report revealed commodities for malaria control, which are: 1. Insecticide-treated nets (ITNs) Between 2014 and 2016, insecticide-treated bednets were told to deliver a total of 582 million insecticide-treated bed nets worldwide. Of this total, 505 million insecticide-treated bed nets were delivered in sub-Saharan Africa, while in the same three-year period (2011-2013), in the same area, there were a total of 301 million bed nets. Data from national malaria control programs in Africa indicate that 75% of insecticide-treated nets delivered between 2014 and 2016 were distributed through mass distribution campaigns. 2. Rapid diagnostic tests According to estimates, the rapid diagnostic tests delivered in 2016 worldwide accounted for 312 million rapid diagnostic tests, of which 269 million were delivered in WHO’s African Region. Between 2010 and 2015, the number of rapid diagnostic tests distributed by national malaria control programs increased, but fell from 247 million rapid diagnostic tests in 2015 to 221 million in 2016. This decline was recorded in sub-Saharan Africa, With the number of rapid diagnostic tests distributed from 219 million to 177 million in 2015-2016. 3. Artemisinin-based combination therapy The number of therapeutic dose regimens of artemisinin-based combination therapies purchased by countries in 2016 was estimated at 409 million therapeutic dosages, an increase of 311 million therapeutic doses . More than 69% of these purchases were reported to be directed to the public sector. The number of therapeutic dose regimens from artemisinin-based combination therapies distributed by national malaria control programs to the public sector increased from 192 million therapeutic dosages in 2013 to 198 million in 2016. Most of these combination therapies were distributed in 2016 Under the framework of those programs to the African Region of the Organization. Malaria prevention is carried out by: Vector control, where household ownership throughout sub-Saharan Africa has increased to at least one insecticide-treated net from 50% in 2010 to 80% in 2016. However, the proportion of households with sufficient nets (ie, One mosquito net per person) is still insufficient, reaching 43% in 2016. At present, an increasing number of people at risk of malaria in Africa are sleeping under an insecticide-treated bednet. The proportion of people protected by this intervention in 2016 rose to 54% from 30% in 2010. Fewer people at risk of malaria have indoor residual spraying protection, a precautionary method of spraying indoor walls with insecticides. The global indoor residual protection rate dropped from 5.8% in 2010 to a peak of 2.9% in 2016, and this decline was seen across all FAO regions. In the African Region, the number of people at risk of malaria with indoor residual spraying has dropped from 80 million in 2010 to 45 million in 2016. The low level of indoor residual spraying coverage is due to countries replacing insecticides with Or use them alternately with these substances. B. Preventive treatment In order to protect women in areas with moderate rates and high rates of malaria transmission in Africa, WHO recommends “intermittent preventive treatment during pregnancy” with sulfadoxine-pyrimethamine antimalarial drug. In African countries 23 which reported levels of coverage for intermittent preventive care during pregnancy in 2016, it is estimated that of the total pregnant women eligible for this treatment, the proportion of recipients of the three or more recommended doses was 19%, while the proportion of recipients was 18% In 2015 and 13% in 2014. In 2016, 15 million children in 12 countries in the Sahel African subregion were protected from malaria by seasonal malaria prevention programs. But it was not covered by some 13 million children who could have benefited from this intervention, mainly due to lack of funding. Since 2012, WHO has recommended the implementation of seasonal seasonal malaria prevention among children aged 3 months and 59 months living in areas with high seasonal malaria incidence in that subregion. The report stressed that rapid diagnosis and treatment is the most effective way to prevent the development of mild malaria cases to severe cases leading to death. The results of surveys conducted at the local level between 2014 and 2016 in 18 countries in sub-Saharan Africa and 61% of the population at risk of malaria indicate that 47% on average, and the spring range of these data is between 38 and 56% Of children with fever (feverish) were taken to trained medical care providers. This included public hospitals and clinics, formal private sector facilities and community health workers. The average number of obese children seeking care in the public sector is 34%. The spring range is 28-44% (the number of private sector applicants is 22%). The spring range is 14%. And 34%). However, surveys in Africa also indicate that a high proportion of feverish children do not receive medical care (an average of 39%, and the spring range of these data is between 29 and 44%). Potential causes include low access to health care providers or lack of awareness of caregivers. The results of 17 local surveys conducted between 2014 and 2016 in sub-Saharan Africa indicate that the number of fever-stricken children who were pricked in one of the fingers or toes in the public sector (52% average, and the spring range of these data) Between 34 and 59%), indicating that they may be tested for malaria diagnosis, than in both the formal and informal sectors. Cases of suspected malaria cases under public health systems have increased since 2010 in most WHO regions. The African Region recorded the highest increase, with the diagnostic test for suspected malaria cases under public health systems in this region increasing from 36% in 2010 to 87% in 2016. The results of 18 household surveys in sub-Saharan Africa between 2014 and 2016 show that the proportion of children under five with fever who gave any of the antimalarial drugs was 41% (the spring range of these data ranges between 21 and 49% The majority of patients receiving 70% of those seeking malaria treatment in the public health sector received artemisinin-based combination therapies, the most effective anti-malarial drug, and children are likely to receive artemisin-based combinations higher if medical care is sought in public health facilities Whether sought in the private sector. To fill the therapeutic gap among children, WHO recommends an integrated community management approach to situations. This approach promotes the integrated management of common childhood life-threatening injuries such as malaria, pneumonia and diarrhea at the health and community levels. In 2016, 26 malaria-affected countries adopted integrated community-based management (ICM) policies, of which 24 had already been implemented. One evaluation from Uganda shows that the provinces that have implemented the ICMP policy have seen an increase in seeking care in cases of fever by 21% compared to districts that have not implemented this policy. Outside FAO’s African Region, only a few countries in each of their respective regions have reported the adoption of an integrated community-based management (ICM) policy, although data on their actual implementation are not available in most of these countries. Effective surveillance of malaria cases and deaths is an imperative for identifying areas affected by malaria or affected populations and for monitoring the resources needed to maximize impact. The strength of the surveillance system requires a high level of access to care and case detection, and the full reporting of cases by all health sectors, public or private. In 2016, 37 out of 46 countries in FAO’s African Region indicated that at least 80% of their public health facilities reported malaria data through their national health information system. Of the 55 countries where the burden of malaria is estimated, the malaria reporting rate for surveillance systems is 50% in 31 countries, including India and Nigeria, which are burdened with malaria. A slogan for “Get Ready to Overcome Malaria” – a slogan that is now on the agenda of this global anti-malaria watch on the Paris-Beauz website, which publishes the most important local, international, and economic news. In order to be in harmony with your privacy, we must inform you that the article “Advice for You” is ready to overcome malaria “… a slogan that is being raised now and at this time in the world now to fight malaria” has been removed from the site “Masrawy” and you can read the news From its original location from here ” Masrawy “Thank you for following us. We hope that we will always be with you.